article · Benha Medical Journal
Background: Coronary artery disease (CAD) and acute myocardial infarction are major causes of death and morbidity worldwide. This study aimed to assess short term clinical outcome in a patient of STEMI after primary PCI by using of APS. Methods: This prospective observational study included 100 patients with ST elevation myocardial infarction (STEMI) and underwent primary PCI within 12 h from symptom onset or between 12 and 24 h with evidence of continuing ischemia. Results: Death occurred in 7 (24.14%) patients in Failed Perfusion group, in 1 (1.49%) patient in Partial perfusion group and in 0 (0%) patients in Full perfusion. Re MI occurred in 5 (16.67%) patients in Failed Perfusion group, in 2 (2.94%) patients in Partial perfusion group and in 0 (0%) patients in Full perfusion. TVR occurred in 6 (20%) patients in Failed Perfusion group, in 2 (2.94%) patients in Partial perfusion group and in 1 (25%) patient in Full perfusion. The composite occurred in 9 (31.03%) patients in Failed Perfusion group, in 1 (1.49%) patient in Partial perfusion group and in 1 (25%) patient in Full perfusion. MACE (death, Re MI, TVR and composite) were significantly different among the three APS groups. mechanical complications were present in 4 (4%) patients. MACE was present in 35 (35%) patients. Regarding MACE, Death occurred in 8 (8%) patients, Re MI in 7 (7%) patients, TVR in 9 (9%) patients and Composite in 11 (11%) patients. Conclusion: The assessment of angiographic perfusion using the APS revealed significant associations with short-term clinical
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/bmfj.2024.284774.2066
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.